EIM
PBLA

Essex Investment Management’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Essex Investment Management’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3
Closed -$225K – 522
2020
Q4 		$225K Hold
3
– – 0.03% 348
2020
Q3 		$231K Buy
+3
New +$210K 0.03% 348

Other funds holding PBLA

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $452M AUM 25.97% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Essex Investment Management's PBLA Position: Q1 2021 in Review

Essex Investment Management sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q1 2021, closing a stake of 3 shares — an estimated $225K sold.

Essex Investment Management first reported a position in PBLA in Q3 2020 and held it in 2 quarters. The position peaked at $231K in Q3 2020. 7 funds tracked by Wall St. Rank hold PBLA as of Q1 2021.

  • Essex Investment Management reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Essex Investment Management sold 3 Panbela Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $225K.
  • Essex Investment Management first reported a position in Panbela Therapeutics, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Essex Investment Management's Panbela Therapeutics, Inc. Common Stock position peaked at $231K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.